BioNTech SE (BNTX) Shares Outstanding (Weighted Average) (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $301.5 million in Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 26123433.74% year-over-year to $301.5 million; the TTM figure through Dec 2025 stood at $301.5 million (up 26123433.74% YoY), while the FY2025 annual figure was $292.6 million, up 25355189.87% from the prior year.
• Shares Outstanding (Weighted Average) grew to $301.5 million in Q4 2025, from $290.6 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $301.5 million in Q4 2025 and bottomed at $900.54 in Q3 2024.
• A 5-year average of $195.6 million and a median of $267.3 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) slumped 100.0% — and 2025, when it jumped 32272436.28%.
• Year by year, Shares Outstanding (Weighted Average) stood at $279.1 million in 2021, then dropped by 11.07% to $248.2 million in 2022, then slumped by 100.0% to $4163.9 in 2023, then plunged by 72.28% to $1154.1 in 2024, then surged by 26123433.74% to $301.5 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $301.5 million (Q4 2025), $290.6 million (Q3 2025), and $281.4 million (Q2 2025), per Business Quant data.

Peer Comparison